Eli Lilly’s oral obesity treatment efficacy falls short of expectations, says BMO’s Evan SeigermanAugust 7, 2025
Share Facebook Twitter LinkedIn Pinterest Email Dan Dolev, Mizuho, joins ‘Closing Bell Overtime’ with reaction to Block earnings as stock pops in extended trading,